Portal:ExRNA/FeaturedPathways
From WikiPathways
(Difference between revisions)
Line 10: | Line 10: | ||
* [[Pathway:WP2011|SREBF and miR33 in cholesterol and lipid homeostasis (Homo sapiens)]] | * [[Pathway:WP2011|SREBF and miR33 in cholesterol and lipid homeostasis (Homo sapiens)]] | ||
* [[Pathway:WP1991|SRF and miRs in Smooth Muscle Differentiation and Proliferation (Homo sapiens)]] | * [[Pathway:WP1991|SRF and miRs in Smooth Muscle Differentiation and Proliferation (Homo sapiens)]] | ||
- | |||
- | |||
{| style="margin: 10px; background-color:#efefef" | {| style="margin: 10px; background-color:#efefef" | ||
Line 18: | Line 16: | ||
|width=100px|{{#pwImage:Pathway:WP2811|250px||mir219 in Oligodendrocyte Differentiation and Myelination}} | |width=100px|{{#pwImage:Pathway:WP2811|250px||mir219 in Oligodendrocyte Differentiation and Myelination}} | ||
[http://dx.doi.org/10.1002/glia.22606 Pusic, et al. Youth and environmental enrichment generate serum exosomes containing miR-219 that promote CNS myelination] | [http://dx.doi.org/10.1002/glia.22606 Pusic, et al. Youth and environmental enrichment generate serum exosomes containing miR-219 that promote CNS myelination] | ||
- | |width=100px|{{#pwImage:Pathway: | + | |width=100px|{{#pwImage:Pathway:WP2805|250px||RNA interference}} |
- | [http://dx.doi.org/10. | + | [http://dx.doi.org/10.1016/j.addr.2013.12.008 Ozpolat, et al. Liposomal siRNA nanocarriers for cancer therapy] |
- | |width=100px|{{#pwImage:Pathway: | + | |width=100px|{{#pwImage:Pathway:WP2870|250px||Extracellular vesicle-mediated signaling in recipient cells}} |
- | [http:// | + | [http://www.mathivananlab.org/publications Gangoda, et al. Extracellular vesicles including exosomes are mediators of signal transduction: Are they protective or pathogenic?] |
|- | |- | ||
- | |width=100px|{{#pwImage:Pathway: | + | |width=100px|{{#pwImage:Pathway:WP2868|250px||TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer}} |
- | [http://dx.doi.org/10.1002/ | + | [http://dx.doi.org/10.1002/msb.20134892 Yang, et al. Metabolic shifts toward glutamine regulate tumor growth, invasion and bioenergetics in ovarian cancer] |
- | + | |width=100px|{{#pwImage:Pathway:WP2866|250px||mir34a and TGIF2 in osteoclastogenesis}} | |
+ | [http://dx.doi.org/10.1038/nature13375 Krzeszinski, et al. miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2] | ||
+ | |width=100px|{{#pwImage:Pathway:WP2865|250px||IL1 and megakaryotyces in obesity}} | ||
+ | [http://dx.doi.org/10.1161/ATVBAHA.113.302700 Beaulieu, et al. Interleukin 1 receptor 1 and interleukin 1beta regulate megakaryocyte maturation, platelet activation, and transcript profile during inflammation in mice and humans] | ||
+ | |width=100px|{{#pwImage:Pathway:WP2864|250px||Apoptosis-related network due to altered Notch3 in ovarian cancer}} | ||
+ | [http://dx.doi.org/10.1158/0008-5472.CAN-13-2066 Hu, et al. Notch3 pathway alterations in ovarian cancer] | ||
+ | |- | ||
+ | |width=100px|{{#pwImage:Pathway:WP2868|250px||TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer}} | ||
+ | [http://dx.doi.org/10.1002/msb.20134892 Yang, et al. Metabolic shifts toward glutamine regulate tumor growth, invasion and bioenergetics in ovarian cancer] | ||
|} | |} |
Revision as of 19:24, 4 November 2014
- miRNA Regulation of DNA Damage Response (Homo sapiens)
- miR-targeted genes in adipocytes - TarBase (Homo sapiens)
- miR-targeted genes in epithelium - TarBase (Homo sapiens)
- miR-targeted genes in leukocytes - TarBase (Homo sapiens)
- miR-targeted genes in lymphocytes - TarBase (Homo sapiens)
- miR-targeted genes in muscle cell - TarBase (Homo sapiens)
- miR-targeted genes in squamous cell - TarBase (Homo sapiens)
- TarBasePathway (Homo sapiens)
- MicroRNAs in cardiomyocyte hypertrophy (Homo sapiens)
- SREBF and miR33 in cholesterol and lipid homeostasis (Homo sapiens)
- SRF and miRs in Smooth Muscle Differentiation and Proliferation (Homo sapiens)
Image does not exist |
Image does not exist |
Image does not exist Ozpolat, et al. Liposomal siRNA nanocarriers for cancer therapy |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |